MEDIROM Healthcare Technologies
MRM
2 hedge funds and large institutions have $1.02M invested in MEDIROM Healthcare Technologies in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.47% more ownership
Funds ownership: 0% → 1.47% (+1.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MS
Mizuho Securities
Tokyo,
Japan
|
+$1.01M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$35.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MS
1
Mizuho Securities
Tokyo,
Japan
| $986K | +$1.01M | +68,500 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $35K | +$35.5K | +2,401 | New |
|
MRM Hedge Fund Activity: Q4 2020 in Review
2 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q4 2020, worth a combined $1.02M.
Buyers outnumbered sellers: 2 funds opened new MRM positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Mizuho Securities, opening a new position worth an estimated $1.01M.
- 2 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $1.02M of MEDIROM Healthcare Technologies stock for Q4 2020.
- 2 funds opened new MEDIROM Healthcare Technologies positions in Q4 2020 and 0 closed out, a net change of +2 holders.
- The largest MEDIROM Healthcare Technologies buyer in Q4 2020 was Mizuho Securities, an estimated $1.01M added.
Based on aggregated 13F filings for Q4 2020.